Luke H. Bradley;Don Marshall Gash;Greg A. Gerhardt
发明人:
Luke H. Bradley,Don Marshall Gash,Greg A. Gerhardt
申请号：
US13586617
公开号：
US20130065830A1
申请日:
2012.08.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.
